go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Alliance Pharmaceuticals Ireland

Alliance Pharmaceuticals Ireland
United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin 24, Ireland
Telephone: + 44 (0)1249 466966
Fax: +44 (0)1249 466 977
Medical Information e-mail: medinfo@alliancepharma.co.uk
Summary of Product Characteristics last updated on medicines.ie: 04/05/2011
SPC Naseptin Nasal Cream

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 04/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.3 - Contraindications
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01-Mar-2011
Legal Category:   Product subject to medical prescription which may be renewed (B)

Free-text change information supplied by the pharmaceutical company



Additions/Changes higlighted in red text:

2.                  QUALITATIVE AND QUANTITATIVE COMPOSITION

 

            Chlorhexidine dihydrochloride         0.1       %w/w

            Neomycin Sulphate                       0.5       %w/w (3250 IU/g)

 

            Excipients: Contains 8% w/w (80mg/g) cetostearyl alcohol

 

            For a full list of excipients, see section 6.1.

 

4.3             Contraindications

 

Hypersensitivity to chlorhexidine and neomycin or to any of the excipients.

            Some patients have shown a hypersensitivity reaction to neomycin or chlorhexidine, although such reactions are extremely rare. 

4.8             Undesirable effects

 

            Local irritation and hypersensitivity can occasionally occur.

 

            Prolonged use may lead to skin sensitisation to neomycin.

 

            Anaphylaxis to chlorhexidine has been reported rarely.


 

5.1             Pharmacodynamic properties

 

            Pharmacotherapeutic group: Other antibiotics for topical use

 

            ATC code: D06AX

 

         

Updated on 04/01/2010 and displayed until 04/05/2011
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
Date of revision of text on the SPC:   01-Dec-2009
Legal Category:   Product subject to medical prescription which may be renewed (B)

Free-text change information supplied by the pharmaceutical company

Section 2: The active ingredient has changed from chlorhexidine hydrochloride to chlorhexidine dihydrochloride
Updated on 16/06/2008 and displayed until 04/01/2010
Reasons for adding or updating:
  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.4 - Special precautions for storage
  • Change to improve clarity and readability
Date of revision of text on the SPC:   06/2008
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

Section 1. Now reads
Naseptin 0.1% & 0.5% w/w Nasal Cream
 
Section 2. Now reads

Chlorhexidine Hydrochloride           0.1       %w/w

Neomycin Sulphate                           0.5       %w/w

 

Excipients: Contains 8% w/w (80mg/g) cetostearyl alcohol

 

For a full list of excipients, see section 6.1.
 
Section 6.4. Now reads

Do not store above 30ºC.  Keep the tube tightly closed. Keep the tube in the outer carton.

Updated on 22/12/2006 and displayed until 16/06/2008
Reasons for adding or updating:
  • Change to section 6.1 - List of excipients
  • Change to section 4.4 - Special warnings and precautions for use
Date of revision of text on the SPC:   12/2005
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

Section 4.4  
Naseptin contains Arachis oil (peanut oil) and should not be taken/applied by patients known to be allergic to peanut. As there is a possible relationship between allergy to peanut and allergy to Soya, patients with Soya allergy should also avoid Naseptin, has been removed.

 

Section 6.1
Excipients changed to medium-chain triglycerides instead of arachis oil.
Updated on 27/11/2006 and displayed until 22/12/2006
Reasons for adding or updating:
  • Change to section 6.1 - List of excipients
Date of revision of text on the SPC:   10/2006
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

The arachis oil excipient has been removed and replaced with medium chain triglycerides
Updated on 16/05/2005 and displayed until 27/11/2006
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use
Updated on 09/03/2005 and displayed until 16/05/2005
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 10 - Date of revision of the text
Updated on 23/06/2003 and displayed until 09/03/2005
Reasons for adding or updating:
  • New SPC for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Neomycin Sulphate
   Chlorhexidine Dihydrochloride

Versions

 
04/05/2011 to Current
04/01/2010 to 04/05/2011
16/06/2008 to 04/01/2010
22/12/2006 to 16/06/2008
27/11/2006 to 22/12/2006
16/05/2005 to 27/11/2006
09/03/2005 to 16/05/2005
23/06/2003 to 09/03/2005
  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo